Literature DB >> 8058316

Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo.

M Grieco1, A Cerrato, M Santoro, A Fusco, R M Melillo, G Vecchio.   

Abstract

H4(D10S170) is a gene which we isolated because of its frequent rearrangement with the RET proto-oncogene in vivo. Its fusion to RET generates the RET/PTC1 oncogene, which has been detected in about 20% of human thyroid papillary carcinomas. We have cloned and sequenced the cDNA corresponding to the H4(D10S170) gene from a human normal thyroid cDNA library. The nucleotide sequence of the H4(D10S170) 3 kb transcript shows no significant homology to known genes and contains an open reading frame (ORF) of 585 amino acids. H4(D10S170) predicted protein has no transmembrane domain and shows extensive regions in the alpha helical conformation, which are 30% homologous to the alpha-helical domains of several proteins including tropomyosin, vimentin, keratin and the tail region of myosin heavy chain. A putative SH3 binding site is present at the carboxy terminus, which suggests that H4(D10S170) might be a cytoskeletal protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058316

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Dissection of the RET/β-catenin interaction in the TPC1 thyroid cancer cell line.

Authors:  Carmen J Tartari; Carla Donadoni; Elisa Manieri; Luca Mologni; Pamela Della Mina; Antonello Villa; Carlo Gambacorti-Passerini
Journal:  Am J Cancer Res       Date:  2011-06-01       Impact factor: 6.166

2.  'Chromosomal Rainbows' Detect Oncogenic Rearrangements of Signaling Molecules in Thyroid Tumors.

Authors:  Benjamin O'Brien; Gregg H Jossart; Yuko Ito; Karin M Greulich-Bode; Jingly F Weier; Santiago Munne; Orlo H Clark; Heinz-Ulrich G Weier
Journal:  Open Cell Signal J       Date:  2010

3.  PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4.

Authors:  Ginny I Chen; Sally Tisayakorn; Claus Jorgensen; Lisa M D'Ambrosio; Marilyn Goudreault; Anne-Claude Gingras
Journal:  J Biol Chem       Date:  2008-08-20       Impact factor: 5.157

4.  Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.

Authors:  Chiara Luise; Francesco Merolla; Vincenza Leone; Simona Paladino; Daniela Sarnataro; Alfredo Fusco; Angela Celetti
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint control.

Authors:  Angeliki Thanasopoulou; Dimitrios J Stravopodis; Konstantinos S Dimas; Juerg Schwaller; Ema Anastasiadou
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

6.  Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage.

Authors:  Francesco Merolla; Chiara Luise; Mark T Muller; Roberto Pacelli; Alfredo Fusco; Angela Celetti
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

7.  Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.

Authors:  B Mayr; E Pötter; P Goretzki; J Rüschoff; W Dietmaier; C Hoang-Vu; H Dralle; G Brabant
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

8.  Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling.

Authors:  Fanny Dubois; Franck Vandermoere; Aurélie Gernez; Jane Murphy; Rachel Toth; Shuai Chen; Kathryn M Geraghty; Nick A Morrice; Carol MacKintosh
Journal:  Mol Cell Proteomics       Date:  2009-08-01       Impact factor: 5.911

9.  Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.

Authors:  Makito Suzuki; Hideki Makinoshima; Shingo Matsumoto; Ayako Suzuki; Sachiyo Mimaki; Koutatsu Matsushima; Kiyotaka Yoh; Koichi Goto; Yutaka Suzuki; Genichiro Ishii; Atsushi Ochiai; Koji Tsuta; Tatsuhiro Shibata; Takashi Kohno; Hiroyasu Esumi; Katsuya Tsuchihara
Journal:  Cancer Sci       Date:  2013-05-12       Impact factor: 6.716

10.  New treatment in advanced thyroid cancer.

Authors:  Dario Giuffrida; Angela Prestifilippo; Alessia Scarfia; Daniela Martino; Stefania Marchisotta
Journal:  J Oncol       Date:  2012-10-22       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.